# FDA Inspection 1302336 - Bloodworks - January 29, 2026

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/1587c8b1-8ffa-49cd-9c0f-efb7b1b9a42f
Source feed: FDA_Inspections

> FDA Inspection 1302336 for Bloodworks on January 29, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302336
- Company Name: Bloodworks
- Inspection Date: 2026-01-29
- Product Type: Biologics
- Office Name: Seattle District Office

## Related Documents

- [FDA Inspection 1302336 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bloodworks/039477ff-ce39-4a2d-9be4-0c531f8a8a16)
- [FDA Inspection 1171899 - 2022-06-01](https://www.keypedia.com/records/fda_inspections/bloodworks/ef57564e-db60-4dc4-8c47-e3ee7619dfb2)
- [FDA Inspection 1171899 - 2022-06-01](https://www.keypedia.com/records/fda_inspections/bloodworks/39c8705d-b565-4b2e-bb8e-1812b013c278)
- [FDA Inspection 1047478 - 2018-04-04](https://www.keypedia.com/records/fda_inspections/bloodworks/43349286-c495-48d9-a9ce-d5513b849229)
- [FDA Inspection 907426 - 2014-12-17](https://www.keypedia.com/records/fda_inspections/bloodworks/d61d5ea8-d889-4dc4-b76c-dbb47b1ab2f6)

Company: https://www.keypedia.com/companies/bloodworks/a297b364-cb83-40aa-a816-03e7edbfb700

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913